This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nipro Corporation. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Shunsuke Daidouji: Innovator in Orodispersible Tablet Technology
Introduction
Shunsuke Daidouji is a prominent inventor based in Osaka, Japan. He is known for his innovative contributions to the pharmaceutical industry, particularly in the development of orodispersible tablets. His work focuses on enhancing the delivery and palatability of medications.
Latest Patents
Shunsuke Daidouji holds a patent for a "Method for producing orodispersible tablets." This method provides an efficient way to produce tablets that ensure effective elution of the principal agent in the digestive tract while masking any unpleasant taste in the oral cavity. The process involves mixing an additive with a principal agent to create granulated particles, coating these particles with a pH-dependent polymer, and finally tableting them to form the finished product. This innovative approach significantly improves the user experience for patients requiring medication.
Career Highlights
Daidouji is associated with Nipro Corporation, a leading company in the medical and pharmaceutical sectors. His work at Nipro has allowed him to focus on developing advanced drug delivery systems that cater to the needs of patients. His dedication to innovation has positioned him as a key figure in the field.
Collaborations
Shunsuke Daidouji collaborates with talented colleagues, including Yohei Hoashi and Naohisa Katayama. Together, they work on various projects aimed at improving pharmaceutical formulations and enhancing patient compliance.
Conclusion
Shunsuke Daidouji's contributions to the field of orodispersible tablets exemplify his commitment to innovation in pharmaceuticals. His patented method not only addresses critical challenges in drug delivery but also enhances the overall patient experience. His work continues to influence the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
